```html

Lyme Borreliosis – A Complete Patient‑Friendly Guide

Overview

Lyme borreliosis, commonly called Lyme disease, is an infection caused by the spirochete bacterium Borrelia burgdorferi (and, in some regions, B. mayonii). The organism is transmitted to humans through the bite of infected Ixodes ticks, often referred to as deer ticks or black‑legged ticks. The disease is most prevalent in the United States, Europe, and parts of Asia where these ticks thrive.

Who it affects: Anyone can be infected, but the highest incidence is among outdoor enthusiasts, children, and adults who work or recreate in wooded or grassy areas. In the United States, about 30,000 cases are reported annually to the CDC, while the CDC estimates that roughly 300,000 people are actually diagnosed each year because many cases go unreported.<sup>[CDC, 2023]</sup> In Europe, an estimated 85,000–130,000 new cases occur each year.<sup>[ECDC, 2022]</sup>

Geographic hotspots include the Northeastern United States (e.g., Connecticut, New York, Massachusetts), the Upper Midwest (Wisconsin, Minnesota), and the Pacific Coast. In Europe, the highest rates are found in Scandinavia, Germany, and the Baltic states.

Symptoms

Lyme disease manifests in three stages—early localized, early disseminated, and late disseminated—though not every patient experiences all stages. Symptoms can overlap with other illnesses, making diagnosis challenging.

Early Localized (3–30 days after bite)

• Erythema migrans (EM) rash – a red, expanding “bull’s‑eye” lesion that may reach 5–70 cm in diameter. It is often painless and may be warm to the touch.
• Flu‑like symptoms – fever, chills, headache, fatigue, muscle & joint aches.
• Neck stiffness – sometimes mimicking meningitis.

Early Disseminated (days to weeks)

• Multiple EM lesions – the rash can appear at sites distant from the bite.
• Neurologic involvement – facial palsy (Bell’s palsy), meningitis, radiculopathy, or peripheral neuropathy causing tingling, numbness, or shooting pain.
• Cardiac involvement – Lyme carditis can cause heart‑block, palpitations, or chest pain.
• Joint pain – often migratory and affecting large joints such as the knee.
• Eye problems – conjunctivitis or uveitis (rare).

Late Disseminated (months to years)

• Chronic arthritis – intermittent swelling and pain, especially in the knees.
• Neuroborreliosis – peripheral neuropathy, memory problems, difficulty concentrating (“brain fog”), sleep disturbances.
• Encephalomyelitis – rare, causing severe cognitive deficits.
• Fatigue – profound, lasting weeks to months after treatment.

Note: Not all patients develop a rash; up to 30 % of cases may lack EM, which can delay recognition.

Causes and Risk Factors

Cause

The disease is caused by Borrelia burgdorferi sensu lato complex bacteria. The pathogen resides in the midgut of unfed nymphal and adult Ixodes ticks. When a tick remains attached to human skin for ≥36–48 hours, bacteria can migrate from the tick’s salivary glands into the bite site and begin replicating.

Risk Factors

• Geography – living or traveling in endemic regions.
• Outdoor exposure – hiking, hunting, gardening, or mowing lawns in tick‑infested areas.
• Seasonality – peak incidence May–July in the Northern Hemisphere when nymphs are most active.
• Clothing – wearing short sleeves/pants that expose skin.
• Pet ownership – dogs and cats can carry attached ticks into the home.
• Immunocompromised state – transplant recipients, HIV patients, or those on chronic steroids may have a higher risk of severe disease.

Diagnosis

Diagnosing Lyme borreliosis relies on a combination of clinical assessment, exposure history, and laboratory testing. Early disease may be diagnosed clinically without serology if the characteristic EM rash is present.

Clinical Evaluation

• Detailed tick exposure history (location, date, duration of attachment).
• Physical exam focusing on rash, cranial nerve function, cardiac auscultation, and joint exam.

Laboratory Tests

1. Two‑Tier Serology (CDC recommended)
   • First tier: Enzyme‑linked immunosorbent assay (ELISA) to detect IgM and IgG antibodies.
   • Second tier: Western blot (immunoblot) for confirmation; separate criteria for IgM (<30 days) and IgG (>30 days).

   Sensitivity is ~40 % in the first week, rising to >90 % after 4–6 weeks.<sup>[Mayo Clinic, 2023]</sup>

2. Polymerase Chain Reaction (PCR) – detects bacterial DNA in joint fluid, cerebrospinal fluid (CSF), or skin biopsies. Useful for neuroborreliosis or Lyme arthritis but less sensitive in blood.
3. CSF Analysis – for suspected meningitis or facial palsy; pleocytosis with elevated protein and positive Lyme antibodies supports neuroborreliosis.
4. Culture – rarely performed because Borrelia is difficult to grow.

Key Diagnostic Points

• Serology should not be performed before 2–3 weeks of symptom onset unless there is a high clinical suspicion and a rash.
• False‑positive results can occur due to other spirochetes, autoimmune diseases, or recent infections; confirm with Western blot.
• Clinical judgment remains paramount; a negative early test does not rule out disease.

Treatment Options

Antibiotics are the cornerstone of therapy. The choice, route, and duration depend on disease stage, symptom severity, and patient age.

Early Localized Disease

• Doxycycline 100 mg orally twice daily for 10–21 days – preferred for adults and children ≥8 years.
• Amoxicillin 500 mg orally three times daily for 14–21 days – alternative for pregnant/breastfeeding women and children <8 years.
• Cefuroxime axetil 500 mg orally twice daily for 14–21 days – another alternative.

Early Disseminated Disease (neurologic or cardiac involvement)

• Doxycycline as above (covers most neurologic manifestations).
• Intravenous ceftriaxone 2 g daily for 14–28 days – indicated for Lyme meningitis, severe radiculopathy, or high‑grade heart block.

Late Disseminated Disease (arthritis, chronic neurologic symptoms)

• Oral doxycycline or amoxicillin for 28 days is typical.
• For persistent arthritis, a 2–4‑week course of IV ceftriaxone may be considered.
• Joint aspiration can be both diagnostic and therapeutic; intra‑articular steroids may be used after antibiotics.

Adjunctive Measures

• Pain management – NSAIDs (ibuprofen, naproxen) for arthralgia.
• Physical therapy – to restore joint range of motion after arthritis resolves.
• Supportive care – adequate sleep, hydration, and nutrition to support immune recovery.

Controversial / Emerging Therapies

Some patients report persistent symptoms despite standard treatment (Post‑Treatment Lyme Disease Syndrome, PTLDS). Current evidence does not support prolonged antibiotics beyond 4 weeks; instead, focus on symptomatic management and multidisciplinary care.<sup>[NIH, 2022]</sup>

Living with Lyme Borreliosis

Even after successful treatment, patients may need to adjust daily habits to manage lingering fatigue, joint discomfort, or neurocognitive symptoms.

Practical Tips

• Energy conservation – schedule rest periods, prioritize tasks, and use assistive devices if needed.
• Joint care – low‑impact exercise (swimming, cycling) to maintain strength without stressing joints.
• Neuro‑cognitive support – use planners, memory aids, and break complex tasks into smaller steps.
• Stress reduction – mindfulness, yoga, or counseling can improve overall well‑being.
• Regular follow‑up – keep appointments with your primary care physician or infectious disease specialist to monitor recovery.

When to Re‑evaluate

If new symptoms emerge (e.g., recurrent joint swelling, worsening fatigue, or new neurologic signs) after completing antibiotics, contact your clinician. Repeat testing (e.g., PCR of synovial fluid) may be indicated.

Prevention

Because Lyme disease is vector‑borne, prevention focuses on avoiding tick bites and removing ticks promptly.

Personal Protective Measures

• Wear long sleeves, long pants, and tuck pant legs into socks when trekking through woods.
• Use EPA‑registered repellents containing 20‑30 % DEET, picaridin, IR3535, or oil of lemon eucalyptus on skin and clothing.
• Apply permethrin (SAINT‑PETER’S®) to clothing and boots; it remains effective through several washings.
• Perform full‑body tick checks every 2–3 hours while outdoors and again at home.

Tick Removal

1. Use fine‑point tweezers; grasp the tick as close to the skin as possible.
2. Pull upward with steady, even pressure—don’t twist or crush the body.
3. Disinfect the bite site with alcohol or iodine.
4. Save the tick in a sealed container (optional) for identification; note the date of removal.

Environmental Strategies

• Keep lawns mowed short and clear leaf litter where ticks thrive.
• Create a “tick‑free” zone by placing gravel or wood chips between woods and recreational areas.
• Use acaricides (tick sprays) on property per local public‑health guidelines.
• Treat pets with veterinarian‑approved tick preventives; regularly check them after outdoor exposure.

Complications

If Lyme disease is left untreated or treatment is delayed, serious complications can develop:

• Lyme carditis – can progress to complete heart block, requiring temporary pacemaker.
• Chronic Lyme arthritis – persistent joint inflammation that may lead to cartilage damage.
• Neuroborreliosis – chronic peripheral neuropathy, encephalopathy, severe mood disorders.
• Acrodermatitis chronica atrophicans – rare skin condition causing thinning and discoloration.
• Post‑Treatment Lyme Disease Syndrome (PTLDS) – long‑term fatigue, pain, and cognitive issues lasting >6 months after therapy.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention (CDC). “Lyme Disease.” 2023. https://www.cdc.gov/lyme/
• European Centre for Disease Prevention and Control (ECDC). “Tick‑borne diseases in Europe.” 2022.
• Mayo Clinic. “Lyme disease: Symptoms and causes.” Updated 2023.
• National Institutes of Health (NIH). “Post‑Treatment Lyme Disease Syndrome.” 2022.
• Cleveland Clinic. “Lyme Disease Treatment.” 2024.
• World Health Organization (WHO). “Vector‑borne diseases: Lyme disease.” 2023.

```